Cytisine for smoking cessation A literature review and a meta-analysis Jean-François ETTER, PhD Institute of social and preventive medicine University.

Slides:



Advertisements
Similar presentations
Jean-François ETTER Evelyne LASZLO Jean-Pierre ZELLWEGER Charles PERROT Thomas PERNEGER University of Geneva, Switzerland Smoking reduction with NRT: a.
Advertisements

Jean-François E T T E R Institute of Social and Preventive Medicine, University of Geneva, Switzerland Contact: J.-F. Etter, IMSP,CMU,case postale, CH-1211.
Understanding and changing professional practice: the use of behaviour change technique methodology Susan Michie and Robert West Professors of Health Psychology,
Pre-cessation nicotine treatment Jean-François ETTER Dr polit. sci, privat docent Institute de Médicine Sociale et Préventive Faculté de Médecine, Université.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Pharmacologic Treatment of Pediatric Headaches El-Chammas K, Keyes J, Thompson N,
1 Who are smokers who use NRT for temporary abstinence ? Jean-François E T T E R, PhD Institute of social and preventive medicine University of Geneva.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2014.
1 Safety education of pedestrian a systematic review O. Duperrex, F. Bunn, I. Roberts Sources of support: Institut de médecine sociale et préventive, Geneva,
PICO Presentation July 29, 2011 Jaclyn Wakita Pharmacy Resident University Hospital of Northern British Columbia.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2008.
CHANTIX (varenicline tartrate ) ROBERT A. SCHWARTZ Executive Vice President Managing Attorney - Houston Attorney in Charge of Mass Tort and Commercial.
Hepatitis web study Hepatitis web study PEG alfa-2a + RBV versus PEG alfa-2a versus INF + RBV APRICOT STUDY Phase 3 Treatment Naïve, Chronic HCV and HIV.
St John’s wort for major depression (Review) Linde, Berner & Kriston (2008/9)
Philip Tønnesen,2005 Smoking cessation Philip Tønnesen, M.D, Dr.med.sci.
Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
Smoking Cessation in Smokers Motivated to Quit Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Robert Anthenelli.
Smoking Cessation Its place in Tobacco Control
Nancy Rigotti, MD Treatment Review: Overview of the Evidence Base for Tobacco Dependence Treatment 10/09/2011.
Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo- controlled, randomised.
Randomized, double-blind, multicenter, controlled trial.
TREVOR VAN MIERLO, BA(HONS), MSCCH (C) PETER SELBY, MBBS, CCFP, MCSC, ASAM, MRO Web Assisted Tobacco Interventions in 2009: A Review of the Current Research.
ALCOHOL USE REDUCTION IN THE COURSE OF SMOKING CESSATION TREATMENT: A REVIEW Robert F. Leeman Stephanie S. O’Malley Yale University School of Medicine.
Neurobiofeedback (NF) and ADHD  Recently two important studies on neurobiofeedback and ADHD have been done in Germany.  The first study was a standard.
Fatima Chaudhry. Why this drug was developed According to the Centers for Disease Control and Prevention (CDC), an estimated 45 million adults in the.
Journal Club Sidharth Bagga MD. Cytisus laborium L. (Golden rain acacia)
The Cigarette Withdrawal Scale CWS-21 Jean-François E T T E R, PhD Institute of social and preventive medicine Faculty of Medicine University of Geneva.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Smoking and Tobacco Related Issues Networking Group (String) AAC R Treating Tobacco Use and Dependence Guidelines Scott Marlow RRT Pulmonary Rehabilitation.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
ABSTINENCE AND RELAPSE AMONG SMOKERS WHO USE VARENICLINE FOR QUITTING—A POOLED ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Shade Agboola, Ann McNeill, Tim.
TOBACCO USE & OLDER SMOKERS. OLDER SMOKERS In 2004, 3.7 million people aged 65 and older were smokers and 16% of all people aged 50 and older smoked;
RevMan for Registrars Paul Glue, Psychological Medicine What is EBM? What is EBM? Different approaches/tools Different approaches/tools Systematic reviews.
Primary Care Conference Case Presentation: A New Smoking Cessation Treatment Option 25 October 2006 Douglas E. Jorenby, Ph.D.
When is a meta-analysis helpful? EBM: 9/18/2012. Evidence-based medicine 25 year old woman presents with an acute migraine. She doesn’t respond to subcutaneous.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
ECONOMIC EVALUATION OF THE USE OF OXYBUTYNIN, TOLTERODINE AND SOLIFENACIN IN PATIENTS WITH OVERACTIVE BLADDER February 6, 2009.
Melissa Natzke Doctor of Pharmacy Candidate
Attempting to increase the use of smoking cessation medications Brendon Baker Ministry of Health.
Background Methods Use of free to use social media to disseminate information in healthcare has increased, but evidence of the effect of this effort is.
The Impact Factor (IF): What Is It Good For? Richard M. Rocco, PhD October
Figure 1. Hazard ratios for progression-free survival analyzed with fixed effect model. Table 1: Relevant trials Table 2. Methodological quality Conclusions.
-Tobacco is the leading preventable cause of disease, disability, and death in the United States (NIDA, 2012). -About 1 in every 5 deaths in the U.S. result.
How to Conduct a Meta-Analysis Arindam Basu MD MPH About the Author Required Browsing.
Varenicline: A Tale of Three Molecules Douglas E. Jorenby, Ph.D. Associate Professor of Medicine Univ. of WI School of Medicine and Public Health The Center.
1 Smoking quiz Robert West University College London Rio de Janeiro 2006.
1 Varenicline for smoking cessation Robert West University College London Logroño, October
Rene Descartes: “I think; therefore I am.”. 3.3: Data Ethics Statistics Chap 3: Designing Experiments.
SHORT RÉSUMÉ: Christopher Goddard. Contact information: Christopher Goddard Office
1 Advising smokers on optimum pharmacotherapy for smoking cessation University College London April 2014 Robert West.
1 Cancer Research UK smoking cessation programme at UCL: Robert West University College London London October 2007.
The Use of Acupuncture to Decrease Neuralgia in Patients with Spinal Cord Injuries Joanna Christiansen PA-S Pacific University School of Physician Assistant.
Clare Meernik, MPH 1 ; Anna McCullough, MSW, MSPH, CTTS 1 ; Leah Ranney, PhD 1 ; Barbara Walsh 2 ; Adam O. Goldstein, MD, MPH 1 Predictors of Quit for.
Adult education institution ‘DANTE’. About us...  Founded in first acknowledged language school in the city of Rijeka  Long experience and tradition.
A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation Michael Camilleri, M.D., Rene Kerstens, M.Sc., An Rykx, Ph.D., and Lieve Vandeplassche,
1 Cytisine for smoking cessation Robert West John Stapleton Magda Cedzynska Paul Aveyard Witold Zatonski.
J Clin Oncol 30: R2 윤경한 / Prof. 김시영 Huan Jin, Dongsheng Tu, Naiqing Zhao, Lois E. Shepherd, and Paul E. Goss.
Columbia / CRF DES vs. BMS Meta-Analysis Kirtane et al, Circ 2009;119:
Hot topics in smoking cessation Robert West University College robertjwest 1.
1 Should behavioural support for smoking cessation address wider psychological problems? University College London October 2013 Robert West.
Pharmacotherapy for Smoking Cessation
Smoking Cessation Medication
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
New Pharmacotherapies for Assisting Smokers in Their Cessation Efforts
Robert West University College London London March 2008
Tobacco Cessation Guidelines for COPD
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Personalized prevention: mobile application for smokers
EVITA Trial design: Smokers admitted with an acute coronary syndrome were randomized to varenicline 1 mg twice daily (n = 151) vs. placebo (n = 151). Study.
Presentation transcript:

Cytisine for smoking cessation A literature review and a meta-analysis Jean-François ETTER, PhD Institute of social and preventive medicine University of Geneva - Switzerland August 28, 2006

Background  Cytisine is found in the seeds of the golden rain tree (Cytisus laburnum).  Cytisine (not to be confounded with cytosine) is an agonist of nicotinic receptors, it binds strongly to alpha4-beta2 nicotinic receptors.  Varenicline is derived from cytisine.  Cytisine has been used to treat tobacco dependence for 40 years in Eastern Europe.  Cytisine is sold as a smoking cessation drug by a Bulgarian firm under the commercial name of Tabex  See

Objectives  To review the literature on the effect of cytisine on smoking cessation.  To conduct a meta-analysis of placebo-controlled trials.

Data sources  We reviewed:. PubMed,. Embase,. Psychological Abstracts,. Biosis,. Google.com and Scholar.google.com,  Using the keywords cytisine, cytisin, zytisin, cytisinum, Tabex and smoking cessation, and  We contacted experts in several countries and the producer of Tabex.  We obtained professional translations of articles in Polish, Bulgarian, Russian and German

Data synthesis  We found 10 studies reporting on the effects of cytisine on smoking cessation,  Including 4 controlled studies (3 placebo-controlled).  9 studies used the Bulgarian drug Tabex, containing 1.5 mg cytisine per tablet.  One Russian study used buccal films containing either 1.5 mg cytisine or 0.75 mg cytisine plus 0.75 mg anabasine.  All studies were published between 1967 and 2005 in Bulgaria, Germany, Poland and Russia.

Data synthesis  There were 4427 smokers treated with cytisine and 3518 smokers in control conditions.  The pooled odds ratio after 3-8 weeks in the 3 placebo- controlled trials (two were doubled-blind and one was randomized) was 1.93 (95% CI: 1.21 to 3.06).  For the 2 placebo-controlled, double-blind trials with longer follow-up, the pooled odds ratio after 3-6 months was 1.83 (1.12 to 2.99).  One placebo-controlled, double-blind trial had follow-up after 2 years (odds ratio=1.77, 1.29 to 2.43).  Some side effects were reported.

Meta-analysis of the effect of cytisine versus placebo on smoking cessation at the end of treatment, after 3-8 weeks

Conclusions  Cytisine is very probably effective for smoking cessation.  Studies of poor methodological quality.  This fact remained largely unnoticed in the English- language literature.  How many other effective drugs are there, which remained unnoticed because efficacy trials were never published in English in Western countries? Competing interests: none Funding: none u Paper published as: Cytisine for smoking cessation: a literature review and a meta-analysis. Arch Intern Med. 2006;166: